BH3 mimetics induce apoptosis independent of DRP-1 in melanoma
Nabanita Mukherjee(University of Colorado Anschutz Medical Campus), Yiqun G. Shellman(University of Colorado Anschutz Medical Campus)
Cited by 27
Related Papers
MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells
|Cell Death and Disease|2020|71
A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine
|Pharmaceuticals|2021|5